Associate Professor, Internal Medicine, Mayo Medical School
Cardiology
Dr. Patricia J. Best, MD
|
|
Give Review
Patricia Best is an expert in the field of Cardiology. She received 1 awards: "Fellow (FACC)". Patricia Best is a published doctor and has 59 publications published. The lastest was: 'The potential usage of dual chamber pacing in patients with implantable cardioverter defibrillators.'
Publications
- SALTIRE-RAAVE: targeting calcific Aortic valve disease LDL-density-radius theory.
- Coronary endothelial dysfunction in patients with early Coronary artery disease is associated with the increase in intravascular lipid core plaque.
- Ultra-low contrast volumes reduce rates of contrast-induced nephropathy in patients with chronic kidney disease undergoing Coronary angiography.
- Eptifibatide vs abciximab as adjunctive therapy during primary percutaneous coronary intervention for Acute myocardial infarction.
- Endothelin-1 receptor blockade prevents renal injury in experimental hypercholesterolemia.
- Incidence and prognostic importance of Acute renal failure after percutaneous coronary intervention.
- Chronic endothelin receptor antagonism prevents Coronary vasa vasorum neovascularization in experimental hypercholesterolemia.
- Acute endothelin-receptor inhibition does not attenuate acetylcholine-induced coronary vasoconstriction in experimental hypercholesterolemia.
- Coronary endothelial function is preserved with chronic endothelin receptor antagonism in experimental hypercholesterolemia in vitro.
- Treatment with endothelin-receptor antagonists increases NOS activity in hypercholesterolemia.
- In vivo renal vascular and tubular function in experimental hypercholesterolemia.
- Outcomes of patients with Chronic renal insufficiency in the bypass angioplasty revascularization investigation.
- Cell adhesion molecules and inflammation in Acute coronary syndromes: markers and emerging risk factors.
- Apoptosis. Basic concepts and implications in Coronary artery disease.
- The safety of treadmill exercise stress testing in patients with abdominal aortic Aneurysms.
- Systemic hypothermia to prevent radiocontrast nephropathy (from the COOL-RCN Randomized Trial).
- The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women.
- Endothelin in cardiovascular disease: from atherosclerosis to Heart failure.
- Multiple skin cancers associated with hydroxyurea therapy.
- The potential usage of dual chamber pacing in patients with implantable cardioverter defibrillators.
- Long-term stability of the place-field activity of single units recorded from the dorsal hippocampus of freely behaving rats.
- Hydroxyurea-induced leg ulceration in 14 patients.
- Medical therapy for rheumatic Heart disease: is it time to be proactive rather than reactive?
- Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive Coronary disease and low to intermediate Framingham score.
- Frequency of allergic or hematologic adverse reactions to ticlopidine among patients with allergic or hematologic adverse reactions to clopidogrel.
- IntraCoronary glycoprotein IIb/IIIa inhibitors from questioning the logic to weighing the data.
- Acute myocardial infarction due to left circumflex artery occlusion and significance of ST-segment elevation.
- Allergic reactions to clopidogrel and cross-reactivity to other agents.
- SCAI consensus document on occupational radiation exposure to the pregnant cardiologist and technical personnel.
- Validation of a predictive risk score for radiocontrast-induced nephropathy following percutaneous Coronary intervention.
- Percutaneous Coronary revascularization for myocardial infarction in chronic kidney disease: recognizing the risk while seizing the benefits.
- Prevention and management of contrast-induced Acute kidney injury.
- The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney Disease: results from the Clopidogrel for th...
- Cardiovascular Disease in older women: a challenge in diagnosis and treatment.
- Metastatic malignant melanoma manifesting as an intracardiac mass.
- Does kidney function alter the benefit of reperfusion therapy for ST-segment elevation Myocardial infarction?
- Can percutaneous Coronary interventions reduce death and myocardial infarction in stable and unstable Coronary disease?
- Perindopril reduced cardiac events in stable Coronary artery disease.
- Clopidogrel-associated autoimmune thrombocytopenic purpura.
- Cardiovascular Disease and chronic kidney Disease: insights and an update.
- Impact of mild or moderate chronic kidney Disease on the frequency of restenosis: results from the PRESTO trial.
- The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: the do Tirofiban and ReoPro Give Similar Efficacy O...
- Incidence, retrieval methods, and outcomes of stent loss during percutaneous Coronary intervention: a large single-center experience.
- Plasma 8-iso-prostaglandin F2alpha, a marker of oxidative stress, is increased in patients with Acute myocardial infarction.
- Evidence-based practice and the nurse practitioner.
- Vascular responses in vivo to 8-epi PGF(2alpha) in normal and hypercholesterolemic pigs.
- Dendroaspis natriuretic peptide relaxes isolated human arteries and veins.
- Chronic kidney Disease as a cardiovascular risk factor.
- Pro: standard percutaneous Coronary intervention is the procedure of choice for myocardial revascularization.
- Endothelin type A receptor antagonism restores Myocardial perfusion response to adenosine in experimental hypercholesterolemia.
- Safety of abciximab in patients with chronic renal insufficiency who are undergoing percutaneous Coronary interventions.
- Nuclear factor-kappaB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable Angina pectoris.
- The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous Coronary interventions.
- Chronic endothelin receptor antagonism preserves Coronary endothelial function in experimental hypercholesterolemia.
- Enhanced Coronary vasoconstriction to oxidative stress product, 8-epi-prostaglandinF2 alpha, in experimental hypercholesterolemia.
- Altered Myocardial microvascular 3D architecture in experimental hypercholesterolemia.
- Hypercholesterolemia impairs Myocardial perfusion and permeability: role of oxidative stress and endogenous scavenging activity.
- Simvastatin preserves Coronary endothelial function in hypercholesterolemia in the absence of lipid lowering.
Schools
Medical College of Pennsylvania
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Ectasia
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
Mayo School of Graduate Medical Education
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1811969967 | |
| NPPES Provider LastName | BEST | |
| NPPES Provider FirstName | PATRICIA | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Cardiology | |
| Total Claim Count | 692.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1811969967 |
| Last Name Of The Provider | BEST |
| First Name Of The Provider | PATRICIA |
| View All |
Similar Doctors
|
|
Dr. William K. Freeman, MD |
|
|
Dr. Teresa S M. Tsang, MD |
|
|
Dr. Carole A. Warnes, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tiffany C. Priester, MD |
|
|
Dr. Barry L. Karon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John A. Schirger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John R. Hoyt, MD |
|
|
Dr. Farris K. Timimi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. R Thomas Tilbury, MD |
|
|
Dr. Thomas M. Munger, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Virend Kristen Somers, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Imran S. Syed, MD |